---
category: news
title: "Apellis to Showcase Leadership in Retina at Association for Research in Vision and ..."
excerpt: "Presentations support the potential of intravitreal pegcetacoplan, an investigational targeted C3 therapy, as the first treatment for geographic atrophy (GA) WALTHAM, Mass., April 16, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals ,"
publishedDateTime: 2021-04-16T16:47:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/business-technology-products-and-services-government-regulations-macular-degeneration-b396e9328172082f29f5d1ccc1975a7e"
webUrl: "https://apnews.com/press-release/globe-newswire/business-technology-products-and-services-government-regulations-macular-degeneration-b396e9328172082f29f5d1ccc1975a7e"
type: article
quality: 16
heat: 16
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "iueKtj36yoLvd3fdsCXTxJASLK/hjxqX+jKGwdAjp3r6iM3E6Ej6ni774jvx8SAI+Ll47WTRPm2gCTSMLqvqfwryxZcK1j7NwFW6nGC5avfhLHh4yGReStE4f2CtjO9MAQ29/Tdm5Wu+dNYr+Ymkjwg5ZnOM+zhH4ISM0ul3bZOYNbBh+ipsHVVomw3PhK0DIogvgEe5fopAt08hjfRPsP1hy1Q3vr9QnrdrsdlPIsI4OdU6uqip0erpLOKm+UgqDycyVyOrkyihESMU+H94QWaIK921U7Fmv2I7HZewm1Yi3WniyhsKJhaePdMcnpDiXy5dABdijXoH7uU8PF02JWWZQnMsF81ENE2sMI7/RRA=;Cu2/Qi/UvIEHpdER/mORvg=="
---

